MORE BIOTECH GROWTH? NOVARTIS CEO SAYS NORTH CAROLINA COULD BE SITE FOR NEW VACCINE PLANT
North Carolina is one of three states under consideration as sites for a new vaccine plant, according to the chief executive officer of Novartis AG. CEO Daniel Vasella told MarketWatch, an online news service, this week that the international pharmaceutical firm could spend as much as $400 million on a new facility.
Local Tech Wire